Natco Pharma Limited (NATCOPHARM)
Business Responsibility and Sustainability Report
Natco Pharma Limited published its Business Responsibility and Sustainability Report for FY 2025-26 on a standalone basis. Key ESG highlights include 18.47% renewable energy use, carbon neutrality target by 2050, 64-65% water recycling at key units, zero reportable safety incidents for employees, 100% ISO 14001 and ISO 45001 certification across manufacturing and R&D sites, and zero data breaches. The company reported 0.56% of revenue spent on employee well-being and strong governance with zero corruption cases. Limited assurance was provided by DNV Business Assurance India Pvt Ltd.
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 NATCOPHARM — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add NATCOPHARM to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Natco Pharma Limited
Important.
The summary above is generated automatically from Natco Pharma Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.